WallStSmart
BGMS

Bio Green Med Solution, Inc.

NASDAQ: BGMS · HEALTHCARE · BIOTECHNOLOGY

$0.94
+41.51% today

Updated 2026-06-05

Market cap
$5.85M
P/E ratio
0.21
P/S ratio
3.84x
EPS (TTM)
$5.03
Dividend yield
52W range
$1 – $20
Volume
2.7M

Bio Green Med Solution, Inc. (BGMS) Financial statements

SEC filings — annual and quarterly data.

Profit margin
-401.34%
Operating margin
-1,128.11%
ROE
-46.07%
ROA
-49.30%
Debt/equity

Margin trends — annual

Gross margin Operating margin Profit margin
YearRevenueNet incomeGross marginOp. marginProfit margin
2006$387000.00$-29.26M-190.44%-8,562.53%-7,560.21%
2007$129000.00$-24.05M-771.32%-24,017.83%-18,645.74%
2008$877000.00$-40.39M-161.23%-3,851.20%-4,605.02%
2009$911000.00$-19.57M-33.15%-1,969.05%-2,148.19%
2010$686000.00$-16.02M-27.55%-2,371.14%-2,335.42%
2011$699000.00$-15.24M48.50%-2,344.49%-2,180.69%
2012$69000.00$-13.19M-21,888.41%-19,110.14%
2013$1.08M$-10.15M-1,658.12%-936.62%
2014$1.73M$-19.39M-954.04%-1,293.94%-1,118.05%
2015$1.94M$-14.34M-536.93%-831.79%-737.76%
2016$843000.00$-11.79M-1,024.20%-1,678.53%-1,398.70%
2017$-7.47M
2018$150000.00$-7.29M-2,784.67%-6,365.33%-4,858.67%
2019$-7.83M
2020$-8.45M
2021$0.00$-18.46M
2022$0.00$-21.20M
2023$420000.00$-22.55M100.00%-6,060.24%-5,370.24%
2024$43000.00$-11.21M100.00%-27,916.28%-26,074.42%
2025$747000.00$-3.00M18.47%-1,128.11%-401.34%

Frequently asked questions

What is Bio Green Med Solution, Inc.'s revenue?

Bio Green Med Solution, Inc.'s trailing twelve-month revenue is $1.52M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is BGMS?

In its most recent fiscal year, BGMS ran a gross margin of 18.47%, an operating margin of -1,128.11%, and a net margin of -401.34%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does BGMS generate?

BGMS produced $-4.77M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is BGMS's balance sheet healthy?

BGMS holds $3.50M in cash and equivalents against — in long-term debt, on $6.84M of shareholder equity. That debt is best read against the cash flow the business throws off each year.